Providing Market Intelligence for 40 Years

In The News

Netflix Reports Lowest Churn As Fifth Of US Broadband Households Cancel OTT In 2015

According to research from Parks Associates, a fifth of broadband US households have cancelled at least one over-the-top (OTT) video service in the past 12 months, up two percentage points from a year ago.

Brett Sappington, senior director of research at Parks, said that Netflix is still the OTT leader in the US, with 52% of all US broadband households subscribing to the service at the end of 2015. Netflix also had the lowest churn rate as a percentage of its total subscriber base. In the past 12 months, just 5% of US broadband households cancelled their Netflix account, including those who cancelled at the end of the trial period. That figure represents 9% of the company’s current subscriber base.

From the articles "Netflix Reports Lowest Churn As Fifth Of US Broadband Households Cancel OTT In 2015" by Michelle Clancy.
 

Previously In The News

59% of broadband-enabled UK households now access video content online

The proportion of UK households with broadband connections utilising the service to access online video content has reached 59%, according to new research. Parks Associates relayed their key findin...

AT&T kills Plenti loyalty program but touts ongoing Thanks campaign

Parks Associates reported last year that 60% of respondents in a survey valued a rewards program for being a loyal customers, third only to the ability to roll over unused data (66%) and free access t...

Over Two-Thirds Of U.S. Smartphone Owners Stream Music Daily

A recent Parks Associates report reveals that 68 percent of U.S. smartphone owners listen to streaming music every day, for an average of 45 minutes per day. Amazon Prime Music emerged as the most pop...

Morning Read: Pharma Changes Afoot As Valeant Courts A New CEO And Novartis U.S. Head Exits

Less than half of caregivers with a smartphone use apps aimed at caregivers, according to a report by Parks Associates. — MobiHealthNews From the article "Morning Read: Pharma Changes Afoot As Vale...